Mannatech Makes Hash Of Ingredient Identities In Label, Online Claims
This article was originally published in The Rose Sheet
Mannatech crosses FDA line on promoting supplements to treat inflammation and tripped on labeling regulations in differentiating MannaBears and other products, according to a warning letter. A second warning published Nov. 21 noted to contract manufacturer Vita-Pure's ingredient testing problems.
You may also be interested in...
CDER says a product marketed as a supplement contains three pharmaceutical ingredients, including phenformin, banned in 1978 because of the occurrence of lactic acidosis in patients. Trade group executives say warnings to 14 firms making diabetes and other disease claims demonstrate that noncompliant businesses will target more health conditions of growing concern to consumers.